Bo Liu

Bo Liu has extensive work experience in the field of oncology research. Bo Liu started as a Research Scientist at Tasly in 2002 before moving on to become a Teaching Assistant at Fordham University in 2004. Bo then joined Mount Sinai Medical Center in 2012 as a Postdoctoral Fellow, where they conducted research on global mRNA decay and developed methods for analyzing RNA decay intermediates. In 2016, Bo Liu became a Senior Research Scientist at Memorial Sloan Kettering Cancer Center, where they worked until 2022. Currently, Bo is a Principal Scientist at Loxo Oncology at Lilly.

Bo Liu has a Ph.D in Cellular and Molecular Biology from Fordham University, which they obtained between 2006 and 2012. Prior to their Ph.D, they earned an MS in Cellular and Molecular Biology from Fordham University from 2004 to 2006. Bo Liu's undergraduate education was completed at Nankai University, where they received a BS in Microbiology from 1998 to 2002.